- Home
- MEOH vs VKTX Comparison
MEOH vs VKTX Comparison
Compare MEOH & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MEOH | VKTX |
|---|---|---|
| Founded | 1968 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MEOH | VKTX |
|---|---|---|
| Price | $63.34 | $30.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $58.33 | ★ $95.86 |
| AVG Volume (30 Days) | 1.6M | ★ 2.2M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.43 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $16.44 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.57 | $22.96 |
| 52 Week High | $66.75 | $43.15 |
Technical Indicators
Market Signals| Indicator | MEOH | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.00 | 35.94 |
| Support Level | $46.36 | $23.08 |
| Resistance Level | $66.75 | $35.85 |
| Average True Range (ATR) | 2.21 | 1.52 |
| MACD | 0.43 | -0.48 |
| Stochastic Oscillator | 81.74 | 20.70 |
Price Performance
Historical ComparisonAbout MEOH Methanex Corporation
Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through an extensive supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.